Efficacy and Safety of Alogliptin-Pioglitazone Combination for Type 2 Diabetes Mellitus Poorly Controlled with Metformin: A Multicenter, Double-Blind Randomized Trial.
- DOI
- 10.4093/dmj.2023.0259
- Published
- 2024-04-23
- Container
- Diabetes Metab J
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.4093/dmj.2023.0259,
title = {Efficacy and Safety of Alogliptin-Pioglitazone Combination for Type 2 Diabetes Mellitus Poorly Controlled with Metformin: A Multicenter, Double-Blind Randomized Trial.},
author = {Park JY and Lee J and Choi YH and Min KW and Han KA and Ahn KJ and Lim S and Kim YH and Ahn CW and Choi KM and Yoon KH.},
year = {2024},
journal = {Diabetes Metab J},
doi = {10.4093/dmj.2023.0259},
url = {https://doi.org/10.4093/dmj.2023.0259}
}RIS
TY - JOUR TI - Efficacy and Safety of Alogliptin-Pioglitazone Combination for Type 2 Diabetes Mellitus Poorly Controlled with Metformin: A Multicenter, Double-Blind Randomized Trial. AU - Park JY AU - Lee J AU - Choi YH AU - Min KW AU - Han KA AU - Ahn KJ AU - Lim S AU - Kim YH AU - Ahn CW AU - Choi KM AU - Yoon KH. PY - 2024 JO - Diabetes Metab J DO - 10.4093/dmj.2023.0259 UR - https://doi.org/10.4093/dmj.2023.0259 ER -
APA
JY, P., J, L., YH, C., KW, M., KA, H., KJ, A., S, L., YH, K., CW, A., KM, C., & KH., Y. (2024). Efficacy and Safety of Alogliptin-Pioglitazone Combination for Type 2 Diabetes Mellitus Poorly Controlled with Metformin: A Multicenter, Double-Blind Randomized Trial.. Diabetes Metab J. https://doi.org/10.4093/dmj.2023.0259
Source records
- europe-pmc · retrieved 2026-09-24T23:49:14.845Z
- doaj · retrieved 2026-09-24T23:49:14.847Z